Supplements

Psoriasis and Psoriatic Arthritis: A Supplement to Dermatology News

Publish date: October 5, 2021

 

Psoriasis and Psoriatic Arthritis: A Supplement to Dermatology News 2021

Read the issue including:

  • Psoriasis severity redefined by expert group
  • Mitigating PSA risk with biologic therapy
  • Lack of diversity seen in psoriasis trials
  • PSA Comorbidities effect on treatment responses

With Commentaries by Joel M. Gelfand, MD, MSCE and Alan Menter, MD

And more…

Read Now

Recommended Reading

Depressive and endothelial dysfunction in PsA: Is there a link?
MDedge Dermatology
Obesity, an added misery in patients with PsA
MDedge Dermatology
PsA patients under anti-TNF therapy show improvement in work productivity
MDedge Dermatology
Worse impact of PsA and associated comorbidities on QoL
MDedge Dermatology
More severe psoriasis linked to an increased risk of PsA
MDedge Dermatology
Acceptance of biosimilars grows but greater use may hinge on switching, interchangeability studies
MDedge Dermatology
NIAMS director reflects on her mentors, spotlights research projects underway
MDedge Dermatology
First-in-class TYK inhibitor shows durable effect for psoriasis
MDedge Dermatology
Clinical Edge Journal Scan Commentary: Psoriasis October 2021
MDedge Dermatology
Nonsteroidal topical found effective for psoriasis in 52-week study
MDedge Dermatology